Which has the lower trailing P/E, COO or GMED?

COO has the lower trailing P/E: COO trades at 18.40 and GMED at 19.07. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, COO or GMED?

Over the past five years, GMED grew revenue faster — COO at a 8.29% CAGR versus GMED at 27.65%.

Is COO or GMED more profitable?

GMED runs the higher net margin — COO at 13.46% versus GMED at 17.03%.

How have COO and GMED total returns compared?

Over the past 10 years, COO delivered 1.62% and GMED delivered 12.38% annualized total return. Past performance doesn't predict future results.

The Cooper Companies, Inc. (COO) vs Globus Medical, Inc. (GMED)

A side-by-side comparison of The Cooper Companies, Inc. and Globus Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 11, 2026. Differences are shown without an overall score or investment verdict.

COO

The Cooper Companies, Inc.

$10.51B

$53.91HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

GMED

Globus Medical, Inc.

$10.01B

$74.19HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

Total return — COO vs GMED

growth of $100 · dividends reinvested · last 10y

COO +16.2% (+1.5%/yr)GMED +217.1% (+12.2%/yr)GMED compounded faster over this window

COO GMED

COO vs GMED: by the numbers

•COO is the larger company ($10.51B vs $10.01B market cap).
•COO trades at the lower trailing earnings multiple (18.40 vs 19.07 P/E), one valuation lens rather than an overall verdict.
•GMED converts more revenue to profit (17.03% vs 13.46% net margin).
•GMED grew revenue faster over the past five years (27.65% vs 8.29% CAGR).

Metrics side by side

Valuation

Metric	COO	GMED
P/E ratio	18.40	19.07
Forward P/E	11.77	14.84
P/S ratio	2.48	3.18
P/B ratio	1.26	2.10
EV / EBITDA	N/A	10.29
FCF yield	N/A	7.50%

Profitability

Metric	COO	GMED
Gross margin	64.75%	68.55%
Operating margin	12.84%	20.75%
Net margin	13.46%	17.03%
ROE	6.85%	11.23%
ROIC	4.76%	10.49%

Growth (annualized)

Metric	COO	GMED
Revenue CAGR (5Y)	8.29%	27.65%
EPS CAGR (5Y)	-17.30%	30.79%
FCF CAGR (5Y)	19.74%	29.93%
Total return CAGR (5Y)	-13.65%	-2.02%

Frequently asked

Which has the lower trailing P/E, COO or GMED?: COO has the lower trailing P/E: COO trades at 18.40 and GMED at 19.07. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, COO or GMED?: Over the past five years, GMED grew revenue faster — COO at a 8.29% CAGR versus GMED at 27.65%.
Is COO or GMED more profitable?: GMED runs the higher net margin — COO at 13.46% versus GMED at 17.03%.
How have COO and GMED total returns compared?: Over the past 10 years, COO delivered 1.62% and GMED delivered 12.38% annualized total return. Past performance doesn't predict future results.

Go deeper

Full COO analysis Full GMED analysis Interactive comparison tool

Dig into the metrics

Cooper Companies P/E ratio Globus Medical P/E ratio Cooper Companies ROE Globus Medical ROE Cooper Companies operating margin Globus Medical operating margin Cooper Companies revenue growth Globus Medical revenue growth Cooper Companies free cash flow Globus Medical free cash flow

Cooper Companies & Globus Medical appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 11, 2026.